A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients

Br J Psychiatry. 1995 May;166(5):650-3. doi: 10.1192/bjp.166.5.650.

Abstract

Background: A study was conducted to validate a comprehensive self-rating scale for measuring side-effects of neuroleptic drugs.

Method: The Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS), which includes 'red herring' items, was twice administered to 50 DSM-III-R schizophrenic patients, who were also interviewed using the UKU side-effect rating scale; 50 unmedicated controls also completed the LUNSERS:

Results: The test-retest reliability of the LUNSERS was good (r = 0.811, P < 0.001) as was its concurrent validity against the UKU (r = 0.828, P < 0.001). Scores correlated with chlorpromazine equivalent doses (r = 0.310, P < 0.02). ROC analysis demonstrated that the scale discriminated between patients and non-medicated controls, who scored differently for real side-effects but not for 'red herring' items.

Conclusions: The LUNSERS is an efficient, reliable and valid method of assessing neuroleptic side-effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination / statistics & numerical data*
  • ROC Curve
  • Reference Values
  • Reproducibility of Results
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology*

Substances

  • Antipsychotic Agents